These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6308493)

  • 21. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
    Koller W; Curtin J; Fields J
    Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.
    Juorio AV
    Br J Pharmacol; 1980 Nov; 70(3):475-80. PubMed ID: 6777007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 24. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors.
    Kuczenski R; Segal DS
    Brain Res; 1999 Mar; 822(1-2):164-74. PubMed ID: 10082894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
    Battisti JJ; Shreffler CB; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 2000 Oct; 67(2):241-6. PubMed ID: 11124387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical and behavioral studies on the mode of action of oxypertine.
    Moroji T; Okuyama T; Hagino Y; Sekiguchi R
    Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine.
    Vécsei L; Telegdy G; Schally AV; Coy DH
    Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
    Klawans HL; Crossett P; Dana N
    Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of morphine with apomorphine: behavioural and biochemical studies.
    Möller HG; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):452-7. PubMed ID: 3821935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
    Feldman DJ; Frank RA; Kehne JH; Flannery R; Brown D; Soni S; Byrd G; Shah S
    Pharmacol Biochem Behav; 1997 Oct; 58(2):565-72. PubMed ID: 9300620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain.
    Fuller RW; Snoddy HD
    Life Sci; 1983 Dec; 33(23):2357-61. PubMed ID: 6645804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis.
    Segal DS; Kuczenski R; Okuda C
    Pharmacol Biochem Behav; 1992 Jul; 42(3):421-9. PubMed ID: 1409775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.
    Nguyen TV; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):366-71. PubMed ID: 2586632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of methylphenidate pretreatment on the behavioral and biochemical responses to amphetamine.
    Kolta MG; Shreve P; Uretsky NJ
    Eur J Pharmacol; 1985 Nov; 117(2):279-82. PubMed ID: 4076347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.